List of Tables
Table 1: Neurodegenerative Disease Drugs Market, Symptoms of AD, PD, MS, HD and ALS, 2017
Table 2: Neurodegenerative Disease Drugs Market, Global, Epidemiology, 2017
Table 3: Neurodegenerative Disease Drugs Market, Global, Alzheimer’s Disease Neurological Tests and Disease Staging, 2017
Table 4: Neurodegenerative Disease Drugs Market, Global, Parkinson’s Disease UPRDS Scale, 2017
Table 5: Neurodegenerative Disease Drugs Market, Global, Parkinson’s Disease Revised Hoehn and Yahr Scale, 2017
Table 6: Neurodegenerative Disease Drugs Market, Global, Huntington’s Disease Unified Huntington’s Disease Rating Scale, 2017
Table 7: Neurodegenerative Disease Drugs Market, Global, Huntington’s Disease Shoulson and Fahn Staging Scale, 2017
Table 8: Neurodegenerative Disease Drugs Market, Global, Amyotrophic Lateral Sclerosis King's Method, 2017
Table 9: Neurodegenerative Disease Drugs Market, Global, Treatment Options Available for Parkinson’s Disease, 2017
Table 10: Neurodegenerative Disease Drugs Market, Global, Approved Indications for Copaxone, 2018
Table 11: Neurodegenerative Disease Drugs Market, Global, Approved Indications for Tecfidera, 2018
Table 12: Neurodegenerative Disease Drugs Market, Global, Approved Indications for Gilenya, 2018
Table 13: Neurodegenerative Disease Drugs Market, Global, Approved Indications for Avonex, 2018
Table 14: Neurodegenerative Disease Drugs Market, Global, Approved Indications for Tysabri, 2018
Table 15: Neurodegenerative Disease Drugs Market, Global, Approved Indications for Ocrevus, 2018
Table 16: Neurodegenerative Disease Drugs Market, Global, Approved Indications for Namenda/Ebixa/Axura/Abixa/Memary, 2018
Table 17: Neurodegenerative Disease Drugs Market, Global, Approved Indications for Aricept, 2018
Table 18: Neurodegenerative Disease Drugs Market, Global, Approved Indications for Azilect, 2018
Table 19: Neurodegenerative Disease Drugs Market, Global, Approved Indications for Neupro, 2018
Table 20: Neurodegenerative Disease Drugs Market, Global, Approved Indications for Radicut 2018
Table 21: Neurodegenerative Disease Drugs Market, Global, Approved Indications for Xenazine, 2018
Table 22: Neurodegenerative Disease Drugs Market, Global, Approved Indications for Spinraza, 2018
Table 23: Neurodegenerative Disease Drugs Market, Global, Usage of Generics Across Key Indications, 2018